"This performance is a direct result of introducing and expanding new products and services, investing in a robust innovation pipeline, controlling expenses, and vertically integrating care to capitalize on customer demand for unified virtual and in-person healthcare experiences," said Jason Gorevic, CEO of Teladoc. Outlook: Teladoc sees third-quarter revenue in the range of $650 million to $675 million versus estimates of $663.11 million. The company anticipates a third-quarter loss of 40 to 50 cents per share versus estimates for a loss of 33 cents per share. Teladoc expects full-year 2023 revenue to be between $2.6 billion and $2.675 billion versus estimates of $2.63 billion. The company sees a full-year earnings loss of $1.25 to $1.60 per share versus estimates for a loss of $1.34 per share.